Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination product containing **esomeprazole**, **amoxicillin**, and **clarithromycin**, used for the eradication of *Helicobacter pylori* (H. pylori).
## Primary Indications
* Treatment of *Helicobacter pylori* infection in patients with duodenal ulcers.
## Adult Dosing
* **Sompraz HP:** One blister pack (containing esomeprazole 20 mg, amoxicillin 1000 mg, and clarithromycin 500 mg) twice daily for 10 days.
* **Note:** Specific dosing regimens may vary. This formulation is designed for a 10-day course.
## Pediatric Dosing
* Dosing has not been established for Sompraz HP in pediatric patients.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustment recommended for esomeprazole, amoxicillin, or clarithromycin within this combination for mild to moderate renal impairment. Use with caution in severe renal impairment.
* **Hepatic Impairment:** No specific dose adjustment recommended for esomeprazole, amoxicillin, or clarithromycin within this combination for mild to moderate hepatic impairment. Use with caution in severe hepatic impairment.
## Contraindications
* Hypersensitivity to esomeprazole, amoxicillin, clarithromycin, or any other macrolide antibiotic.
* History of allergic reactions to penicillin or cephalosporins.
* Concomitant use with pimozide, cisapride, terfenadine, or astemizole due to risk of QT prolongation.
* Patients with a history of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
## Adverse Effects
* **Common:** Diarrhea, nausea, abdominal pain, taste disturbance, headache, rash, fungal infections.
* **Serious:** *Clostridium difficile*-associated diarrhea (CDAD), severe allergic reactions (including anaphylaxis), *Stevens-Johnson syndrome*, *toxic epidermal necrolysis*, hepatic dysfunction, QT prolongation, *myasthenia gravis* exacerbation.
## Key Drug Interactions
* **Esomeprazole:** Can decrease the absorption of drugs requiring gastric acidity (e.g., ketoconazole, itraconazole, digoxin). May increase levels of drugs metabolized by CYP2C19 (e.g., clopidogrel, voriconazole) and CYP3A4 (e.g., warfarin, cyclosporine).
* **Clarithromycin:** Potent inhibitor of CYP3A4, can increase levels of many drugs (e.g., statins, calcium channel blockers, benzodiazepines, colchicine, theophylline, digoxin). May interact with warfarin and oral contraceptives.
* **Amoxicillin:** May decrease the efficacy of oral contraceptives.
## Monitoring
* Monitor for signs and symptoms of allergic reactions.
* Assess for signs and symptoms of CDAD.
* Evaluate for therapeutic response (e.g., resolution of symptoms, confirmation of H. pylori eradication).
* Monitor liver function tests if hepatic impairment is suspected.
## Clinical Pearls
* This combination is a 10-day treatment regimen. Ensure patients complete the full course.
* Administer the esomeprazole component at least 1 hour before meals.
* Educate patients on the importance of taking all medications as prescribed.
* Advise patients to report any severe diarrhea, rash, or signs of allergic reaction immediately.
* Clarithromycin has a bitter taste; consider co-administration with a non-sugared beverage or food.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and local protocols before making any treatment decisions.
